Roshawn A. Blunt - Net Worth and Insider Trading

Roshawn A. Blunt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roshawn A. Blunt owns 3 companies in total, including DMK Pharmaceuticals Corp (DMKPQ) , Kronos Bio Inc (KRON) , and Reneo Pharmaceuticals Inc (RPHM) .

Click here to see the complete history of Roshawn A. Blunt’s form 4 insider trades.

Insider Ownership Summary of Roshawn A. Blunt

Ticker	Comapny	Transaction Date	Type of Owner
DMKPQ	DMK Pharmaceuticals Corp	2019-08-26	director
KRON	Kronos Bio Inc	2021-11-11	director
RPHM	Reneo Pharmaceuticals Inc	2022-08-02	director

Roshawn A. Blunt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Roshawn A. Blunt Ownership Network

Ownership Network List of Roshawn A. Blunt

No Data

Ownership Network Relation of Roshawn A. Blunt

Roshawn A. Blunt Owned Company Details

What does DMK Pharmaceuticals Corp do?

Who are the key executives at DMK Pharmaceuticals Corp?

Roshawn A. Blunt is the director of DMK Pharmaceuticals Corp. Other key executives at DMK Pharmaceuticals Corp include General Counsel Dorbin John W. Jr. , CFO Seth Cohen , and director & CEO Ebrahim Versi .

DMK Pharmaceuticals Corp (DMKPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DMK Pharmaceuticals Corp (DMKPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DMK Pharmaceuticals Corp (DMKPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DMK Pharmaceuticals Corp (DMKPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DMK Pharmaceuticals Corp Insider Transactions

No Available Data

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Roshawn A. Blunt is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Roshawn A. Blunt made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .

In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kronos Bio Inc Insider Transactions

No Available Data

What does Reneo Pharmaceuticals Inc do?

Who are the key executives at Reneo Pharmaceuticals Inc?

Roshawn A. Blunt is the director of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .

Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary

Over the past 18 months, Roshawn A. Blunt made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard , a net sale of 100,000 shares made by Novo Holdings A/s , and a net sale of 15,625 shares made by Ashley Hall .

In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 78,520 shares, with a net purchase of 78,520 shares. During the past 18 months, 11,563 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 119,948 shares were bought by its insiders, resulting in a net purchase of 108,386 shares.

Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reneo Pharmaceuticals Inc Insider Transactions

No Available Data

Roshawn A. Blunt Mailing Address

Above is the net worth, insider trading, and ownership report for Roshawn A. Blunt. You might contact Roshawn A. Blunt via mailing address: 11682 El Camino Real Ste 300, San Diego Ca 92130.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.